Lin Ting-Wei, Tsai Meng-Ta, Hu Yu-Ning, Lin Wei-Hung, Wang Wei-Ming, Luo Chwan-Yau, Roan Jun-Neng
Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ann Thorac Surg. 2017 Sep;104(3):827-833. doi: 10.1016/j.athoracsur.2017.01.059. Epub 2017 Mar 6.
Few studies have investigated the use of postoperative extracorporeal membrane oxygenation (ECMO) in acute type A aortic dissection (aTAAD). We identified aTAAD surgical patients at risk of ECMO implantation postoperatively and analyzed the prognosis of these patients.
We retrospectively reviewed 162 consecutive aTAAD patients undergoing operations from January 2008 to December 2015. Patient data were analyzed for risk factors leading to an ECMO requirement. Short-term and long-term outcomes in patients who did and did not require ECMO were compared.
Postoperative ECMO was required in 20 patients (12.3%), and in-hospital mortality was higher in the ECMO group (65.0% vs 8.5%, p < 0.001). Factors predicting postoperative ECMO were preoperative hemodynamic instability (p = 0.049), aortic cross-clamp time (p = 0.036), and postoperative peak creatinine kinase-MB (p = 0.002). ECMO survivors presented at a younger age (p = 0.036) and had a less postoperative blood transfusion (p = 0.034) than ECMO nonsurvivors. The postdischarge survival rate was equivalent in patients with or without ECMO support.
Although postoperative ECMO is an important predictor of in-hospital death, this pilot study showed that aTAAD patients supported with postoperative ECMO who survive to hospital discharge have a long-term survival comparable to patients who did not receive ECMO.
很少有研究调查过急性A型主动脉夹层(aTAAD)术后体外膜肺氧合(ECMO)的使用情况。我们确定了术后有植入ECMO风险的aTAAD手术患者,并分析了这些患者的预后情况。
我们回顾性分析了2008年1月至2015年12月期间连续接受手术的162例aTAAD患者。分析患者数据以找出导致需要使用ECMO的危险因素。比较了需要和不需要ECMO的患者的短期和长期结局。
20例患者(12.3%)术后需要使用ECMO,ECMO组的院内死亡率更高(65.0% 对8.5%,p < 0.001)。预测术后需要使用ECMO的因素包括术前血流动力学不稳定(p = 0.049)、主动脉阻断时间(p = 0.036)和术后肌酸激酶同工酶峰值(p = 0.002)。与未存活的ECMO患者相比,存活的ECMO患者年龄更小(p = 0.036),术后输血更少(p = 0.034)。有无ECMO支持的患者出院后的生存率相当。
虽然术后ECMO是院内死亡的重要预测指标,但这项初步研究表明,术后接受ECMO支持且存活至出院的aTAAD患者的长期生存率与未接受ECMO的患者相当。